Levetiracetam, Phenytoin, and Valproic Acid Combination

This is a combination of three distinct antiepileptic drugs: Levetiracetam, Phenytoin, and Valproic Acid. These drugs are sometimes used together in the treatment of epilepsy and seizure disorders, particularly in patients with difficult-to-treat (refractory) epilepsy who have not responded adequately to monotherapy or dual therapy with antiepileptic medications. Each component has its own mechanism of action, side effects, and clinical considerations. Levetiracetam works by attaching to the synaptic vesicle protein SV2A, resulting in a nonspecific decrease in neurotransmitter release. Phenytoin blocks voltage-gated sodium channels. Valproic acid primarily works by raising the level of GABA in the brain. When used in combination, these drugs may have synergistic effects, but also potential for increased side effects and drug interactions. For example, valproic acid should be used cautiously with phenytoin due to significant interactions. Levetiracetam is considered equally effective compared to other agents like fosphenytoin or valproic acid, but has a superior safety profile, making it a preferred choice in many clinical scenarios.

Brand names

Epival